Disabling of the erbB Pathway Followed by IFN-γ Modifies Phenotype and Enhances Genotoxic Eradication of Breast Tumors

Yasuhiro Nagai(University of Pennsylvania), Mark I. Greene(University of Pennsylvania), Hiromichi Tsuchiya(University of Pennsylvania), Jeffrey A. Drebin(Memorial Sloan Kettering Cancer Center), Hongtao Zhang(Chinese Academy of Sciences), Mei Ji(The First People's Hospital of Changzhou), Peter D. Young(University of Pennsylvania), E. Aaron Runkle(University of Pennsylvania), Larry Norton(Memorial Sloan Kettering Cancer Center)

Cell Reports

September 1, 2015

Cited by 25

|Annals of Oncology|2016|2.1k

|Annals of Oncology|2020|1.4k

|Annals of Oncology|2018|1.2k

|Journal of Clinical Oncology|2000|746

|Nature Genetics|2020|739

Related Papers